Results 11 to 20 of about 1,321,319 (311)

Experimental In Vivo Models of Candidiasis [PDF]

open access: yesJournal of Fungi, 2018
Candidiasis is a multifaceted fungal disease including mucosal-cutaneous, visceral, and disseminated infections caused by yeast species of the genus Candida. Candida infections are among the most common human mycoses. Candida species are the third to fourth most common isolates from bloodstream infections in neutropenic or immunocompromised ...
Esther Segal, Michael Frenkel
openaire   +4 more sources

In Vitro, Ex Vivo, and In Vivo Models for the Study of Pemphigus

open access: yesInternational Journal of Molecular Sciences, 2022
Pemphigus is a life-threatening autoimmune disease. Several phenotypic variants are part of this family of bullous disorders. The disease is mainly mediated by pathogenic autoantibodies, but is also directed against two desmosomal adhesion proteins, desmoglein 1 (DSG1) and 3 (DSG3), which are expressed in the skin and mucosae.
Roberta Lotti   +4 more
openaire   +2 more sources

Modeling metastasis in vivo [PDF]

open access: yesCarcinogenesis, 2004
Metastasis, the spread of a tumor from its primary site to other parts of the body, continues to be the most significant problem in the field of cancer. Patients who present with metastatic disease or those who develop metastases after successful management of the primary tumor carry a universally grave prognosis.
Chand, Khanna, Kent, Hunter
openaire   +2 more sources

Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models

open access: yesmAbs, 2020
Monoclonal antibodies (mAbs) are among the fastest growing and most effective therapies for myriad diseases. Multispecific antibodies are an emerging class of novel therapeutics that can target more than one tumor- or immune-associated modulators per ...
Delphine Valente   +12 more
doaj   +1 more source

In vivo cerebral aneurysm models [PDF]

open access: yesNeurosurgical Focus, 2019
Cerebral aneurysm rupture is a devastating event resulting in subarachnoid hemorrhage and is associated with significant morbidity and death. Up to 50% of individuals do not survive aneurysm rupture, with the majority of survivors suffering some degree of neurological deficit.
John W, Thompson   +9 more
openaire   +2 more sources

Lentiviral vector induces high-quality memory T cells via dendritic cells transduction

open access: yesCommunications Biology, 2021
Ku et al. report a lentiviral (LV) vector system in which expression of vaccine antigens is driven by β2-microglobulin (β2m) promoter. Conducting comparative studies in mice and rats, they find that LV-based vaccine outperforms the ‘gold-standard’ Ad5 by
Min Wen Ku   +7 more
doaj   +1 more source

In Vivo and Ex Vivo Pediatric Brain Tumor Models: An Overview

open access: yesFrontiers in Oncology, 2021
After leukemia, tumors of the brain and spine are the second most common form of cancer in children. Despite advances in treatment, brain tumors remain a leading cause of death in pediatric cancer patients and survivors often suffer from life-long ...
Zhiqin Li, Sigrid A. Langhans
doaj   +1 more source

In vivo models of angiogenesis [PDF]

open access: yesJournal of Cellular and Molecular Medicine, 2006
The process of building new blood vessels (angiogenesis) and controlling the propagation of blood vessels (anti-angiogenesis) are fundamental to human health, as they play key roles in wound healing and tissue growth. More than 500 million people may stand to benefit from anti- or pro-angiogenic treatments in the coming decades [National Cancer ...
openaire   +2 more sources

Emerging cancer models for drugs and novel dosages development [PDF]

open access: yesWorld Cancer Research Journal, 2022
Objective: Cancer is the primary cause of death all over the world, despite of its early detection and novel therapies available. The process of cancer drug development is growing tremendously.
P. Das, M. Das
doaj   +1 more source

Diabetic retinopathy: a comprehensive update on in vivo, in vitro and ex vivo experimental models

open access: yesBMC Ophthalmology, 2023
Diabetic retinopathy (DR), one of the leading causes of visual impairment and blindness worldwide, is one of the major microvascular complications in diabetes mellitus (DM). Globally, DR prevalence among DM patients is 25%, and 6% have vision-threatening
Muhammad Zulfiqah Sadikan   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy